Prediction of type 2 diabetes using machine learning classification methods NP Tigga, S Garg Procedia Computer Science 167, 706-716, 2020 | 327 | 2020 |
Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study T Stephenson, SMP Pereira, R Shafran, BL De Stavola, N Rojas, ... The Lancet Child & Adolescent Health 6 (4), 230-239, 2022 | 219 | 2022 |
Neurofibromatosis type 1 and autism spectrum disorder S Garg, J Green, K Leadbitter, R Emsley, A Lehtonen, DG Evans, ... Pediatrics 132 (6), e1642-e1648, 2013 | 194 | 2013 |
Autism and other psychiatric comorbidity in neurofibromatosis type 1: Evidence from a population‐based study S Garg, A Lehtonen, SM Huson, R Emsley, D Trump, DG Evans, J Green Developmental Medicine & Child Neurology 55 (2), 139-145, 2013 | 186 | 2013 |
Annual research review: the state of autism intervention science: progress, target psychological and biological mechanisms and future prospects J Green, S Garg Journal of Child Psychology and Psychiatry 59 (4), 424-443, 2018 | 149 | 2018 |
Production of thermo-alkali-stable laccase and xylanase by co-culturing of Bacillus sp. and B. halodurans for biobleaching of kraft pulp and deinking of waste paper V Gupta, S Garg, N Capalash, N Gupta, P Sharma Bioprocess and biosystems engineering 38, 947-956, 2015 | 123 | 2015 |
Disease burden and symptom structure of autism in neurofibromatosis type 1: a study of the International NF1-ASD Consortium Team (INFACT) SM Morris, MT Acosta, S Garg, J Green, S Huson, E Legius, KN North, ... JAMA psychiatry 73 (12), 1276-1284, 2016 | 118 | 2016 |
Temporal trends in annual incidence rates for psychiatric disorders and self-harm among children and adolescents in the UK, 2003–2018 L Cybulski, DM Ashcroft, MJ Carr, S Garg, CA Chew-Graham, N Kapur, ... BMC psychiatry 21, 1-12, 2021 | 92 | 2021 |
Comprehensive RNA analysis of the NF1 gene in classically affected NF1 affected individuals meeting NIH criteria has high sensitivity and mutation negative testing is … DG Evans, N Bowers, E Burkitt-Wright, E Miles, S Garg, V Scott-Kitching, ... EBioMedicine 7, 212-220, 2016 | 85 | 2016 |
Autism spectrum disorder profile in neurofibromatosis type I S Garg, E Plasschaert, MJ Descheemaeker, S Huson, M Borghgraef, ... Journal of autism and developmental disorders 45, 1649-1657, 2015 | 80 | 2015 |
Randomised controlled trial of simvastatin treatment for autism in young children with neurofibromatosis type 1 (SANTA) S Stivaros, S Garg, M Tziraki, Y Cai, O Thomas, J Mellor, AA Morris, C Jim, ... Molecular autism 9, 1-13, 2018 | 74 | 2018 |
Temporal trends in antidepressant prescribing to children in UK primary care, 2000–2015 J Sarginson, RT Webb, SJ Stocks, A Esmail, S Garg, DM Ashcroft Journal of affective disorders 210, 312-318, 2017 | 58 | 2017 |
Autism spectrum disorder and other neurobehavioural comorbidities in rare disorders of the Ras/MAPK pathway S Garg, A Brooks, A Burns, E Burkitt‐Wright, B Kerr, S Huson, R Emsley, ... Developmental Medicine & Child Neurology 59 (5), 544-549, 2017 | 55 | 2017 |
Cognition in children with neurofibromatosis type 1: Data from a population‐based study A Lehtonen, S Garg, SA Roberts, D Trump, DG Evans, J Green, ... Developmental Medicine & Child Neurology 57 (7), 645-651, 2015 | 49 | 2015 |
Sex bias in autism spectrum disorder in neurofibromatosis type 1 S Garg, H Heuvelman, S Huson, H Tobin, J Green, ... Journal of neurodevelopmental disorders 8, 1-8, 2016 | 32 | 2016 |
Temporal trends in eating disorder and self-harm incidence rates among adolescents and young adults in the UK in the 2 years since onset of the COVID-19 pandemic: a population … AM Trafford, MJ Carr, DM Ashcroft, CA Chew-Graham, E Cockcroft, ... The Lancet Child & Adolescent Health 7 (8), 544-554, 2023 | 28 | 2023 |
Liquid ammonia pretreatment optimization for improved release of fermentable sugars from sugarcane bagasse M Hans, S Garg, VOA Pellegrini, JG Filgueiras, ER de Azevedo, ... Journal of cleaner production 281, 123922, 2021 | 25 | 2021 |
Cognitive and electrophysiological correlates of working memory impairments in neurofibromatosis type 1 G Pobric, JR Taylor, HM Ramalingam, E Pye, L Robinson, G Vassallo, ... Journal of autism and developmental disorders 52 (4), 1478-1494, 2022 | 23 | 2022 |
Early development of infants with neurofibromatosis type 1: a case series AM Kolesnik, EJH Jones, S Garg, J Green, T Charman, MH Johnson Molecular Autism 8, 1-13, 2017 | 22 | 2017 |
Autism spectrum disorder symptom profile across the RASopathies MM Geoffray, B Falissard, J Green, B Kerr, DG Evans, S Huson, ... Frontiers in Psychiatry 11, 585700, 2021 | 18 | 2021 |